VALIANTLAB

Valiant Laboratories Share Price

₹108.96 -4.26 (-3.76%)

20 Jun, 2025 05:33

SIP TrendupStart SIP in VALIANTLAB

Start SIP

Performance

  • Low
  • ₹108
  • High
  • ₹116
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹157
  • Open Price₹111
  • Previous Close₹113
  • Volume39,240

Investment Returns

  • Over 1 Month + 5.49%
  • Over 3 Month + 30.29%
  • Over 6 Month -2.41%
  • Over 1 Year -25.81%
SIP Lightning

Smart Investing Starts Here Start SIP with Valiant Laboratories for Steady Growth!

Invest Now

Valiant Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -215.1
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 473
  • P/B Ratio
  • 2
  • Average True Range
  • 5.4
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.65
  • RSI
  • 51.06
  • MFI
  • 86.68

Valiant Laboratories Financials

Valiant Laboratories Technicals

EMA & SMA

Current Price
₹108.96
-4.26 (-3.76%)
pointer
  • stock-down_img
  • Bearish Moving Average 8
  • stock-up_img
  • Bullish Moving Average 8
  • 20 Day
  • ₹109.92
  • 50 Day
  • ₹104.47
  • 100 Day
  • ₹103.00
  • 200 Day
  • ₹110.32

Resistance and Support

110.77 Pivot Speed
  • R3 122.24
  • R2 119.02
  • R1 113.99
  • S1 105.74
  • S2 102.52
  • S3 97.49

What's your outlook on Valiant Laboratories?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Valiant Laboratories Ltd has an operating revenue of Rs. 133.38 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 45%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 11 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valiant Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-20 Audited Results
2025-02-07 Quarterly Results & Others To consider other business matters.
2024-11-12 Quarterly Results
2024-08-12 Quarterly Results
2024-05-14 Audited Results

Valiant Laboratories F&O

Valiant Laboratories Shareholding Pattern

74.94%
0.64%
16.29%
8.13%

About Valiant Laboratories

  • NSE Symbol
  • VALIANTLAB
  • BSE Symbol
  • 543998
  • Managing Director
  • Mr. Santosh S Vora
  • ISIN
  • INE0JWS01017

Similar Stocks to Valiant Laboratories

Valiant Laboratories FAQs

Valiant Laboratories share price is ₹108 As on 20 June, 2025 | 05:19

The Market Cap of Valiant Laboratories is ₹473.4 Cr As on 20 June, 2025 | 05:19

The P/E ratio of Valiant Laboratories is -215.1 As on 20 June, 2025 | 05:19

The PB ratio of Valiant Laboratories is 2 As on 20 June, 2025 | 05:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23